ARCHIVES

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

This article is from The Cancer Letter archive.

Vol. 06 No. 26 | June 27, 1980

Download PDF Visit The Full Archive

Related Articles

NCAB Votes To Return P01 Review To Pre-1987 System, Two-Tier Review

May 14, 1993

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

November 10, 1989

Cancergrams Cost $840 Year For All

December 2, 1977

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

In Brief: Rall Says He’ll Return Money To NCI If There Isn’t Any Left; OMB Releases 28 Positions For NTP

February 1, 1980

Special Report on the American Legacy Foundation: As Legacy seeks new funding, critics fear symbiosis with Big Tobacco. Legacy, NCI, C-Change relationship could open door to industry influence, lawyer says.

October 29, 2004